GlaxoSmithKline to invest Rs2 billion in Pakistan

KARACHI: GlaxoSmithKline (GSK) Consumer Healthcare has announced a plan to invest Rs2 billion to develop healthcare products in Pakistan of international standard, Paul Marson, head of finance of GSK Consumer Healthcare, Middle East said on Monday.

“Rs2 billion is our initial investment budget for Pakistan,” said Paul Marsonat while addressing a product launching ceremony here. He said that the company is expending its healthcare products business beyond the Middle East. Pakistan is one of the company’s priority countries for investment now, he said.

He said he hoped to earn 50 percent sales revenue from these new investments in the years to come. Turkey and Egypt are two other new investment countries.

Speaking on the occasion Sohail Matin, general manager of GSK Consumer Healthcare Business in Pakistan, said that the company will soon introduce new line of health care products in the country. He claimed that the company is making healthcare products of international quality.

Leave a Reply